Back
Viridian Therapeutics, Inc. Stock Price Chart
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Buy
59
VRDN
Viridian Therapeutics, Inc.
Last Price:
$33.25
Seasonality Move:
-12.78%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRDN is experiencing slight buying pressure.
Viridian Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.72 | Sell |
| 20-day SMA: | 31.8 | Buy |
| 50-day SMA: | 31.28 | Buy |
| 200-day SMA: | 20.73 | Buy |
| 8-day EMA: | 7.15 | Buy |
| 20-day EMA: | 3.06 | Buy |
| 50-day EMA: | 1.26 | Buy |
| 200-day EMA: | 0.32 | Buy |
Viridian Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.57 | Buy |
| Relative Strength Index (14 RSI): | 53.14 | Buy |
| Chaikin Money Flow: | 654204 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Viridian Therapeutics, Inc. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viridian Therapeutics, Inc. Stock
Is Viridian Therapeutics, Inc. Stock a Buy?
-
Viridian Therapeutics, Inc. share price is 32.17 while VRDN 8-day simple moving average is 32.72, which is a Sell signal.
-
The stock price of VRDN is 32.17 while Viridian Therapeutics, Inc. 20-day SMA is 31.80, which makes it a Buy.
-
Viridian Therapeutics, Inc. 50-day simple moving average is 31.28 while VRDN share price is 32.17, making it a Buy technically.
-
VRDN stock price is 32.17 and Viridian Therapeutics, Inc. 200-day simple moving average is 20.73, creating a Buy signal.
VRDN Technical Analysis vs Fundamental Analysis
Buy
59
Viridian Therapeutics, Inc. (VRDN)
is a Buy
Is Viridian Therapeutics, Inc. a Buy or a Sell?
-
Viridian Therapeutics, Inc. stock is rated a BuyThe current Viridian Therapeutics, Inc. [VRDN] share price is $32.17. The Score for VRDN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Viridian Therapeutics, Inc. Stock Info
Market Cap:
3.1B
Price in USD:
32.17
Share Volume:
2.1M
Viridian Therapeutics, Inc. 52-Week Range
52-Week High:
34.29
52-Week Low:
9.90
Buy
59
Viridian Therapeutics, Inc. (VRDN)
is a Buy
Viridian Therapeutics, Inc. Share Price Forecast
-
What is the Viridian Therapeutics, Inc. stock price today?The Viridian Therapeutics, Inc. stock price is 32.17 USD today.
-
Will VRDN stock go up or go down?Viridian Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Viridian Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viridian Therapeutics, Inc. is not overvalued.
Is Viridian Therapeutics, Inc. Stock a Buy?
-
Viridian Therapeutics, Inc. share price is 32.17 while VRDN 8-day exponential moving average is 7.15, which is a Buy signal.
-
The stock price of VRDN is 32.17 while Viridian Therapeutics, Inc. 20-day EMA is 3.06, which makes it a Buy.
-
Viridian Therapeutics, Inc. 50-day exponential moving average is 1.26 while VRDN share price is 32.17, making it a Buy technically.
-
VRDN stock price is 32.17 and Viridian Therapeutics, Inc. 200-day simple moving average is 0.32, creating a Buy signal.
Fundamental Analysis of Viridian Therapeutics, Inc.
Is Viridian Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $1.85 per share.
Technical Analysis of Viridian Therapeutics, Inc.
Should I short Viridian Therapeutics, Inc. stock?
-
VRDN Moving Average Covergence Divergence (MACD) indicator is 2.57, suggesting Viridian Therapeutics, Inc. is a Buy
-
Viridian Therapeutics, Inc. Relative Strength Index (RSI) is 53.14, which suggest Viridian Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Viridian Therapeutics, Inc. is ( - ), which suggest Viridian Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Viridian Therapeutics, Inc. is ( - ), which suggest Viridian Therapeutics, Inc. is a Buy
* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.